Local and systemic therapy for patients with metastatic prostate cancer: should the primary tumor be treated?

Edith D. Canby-Hagino, Gregory P Swanson, E. David Crawford, Joseph W Basler, Javier Hernandez, Ian M. Thompson

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Data from well-designed, prospective clinical trials are lacking to support treatment of primary tumor in men diagnosed with metastatic prostate cancer. However, a growing body of evidence suggests that treatment of the primary tumor may enhance cancer control and survival in some men. This evidence is examined and recommendations are made for identifying patients with metastatic prostate cancer who may benefit from definitive treatment of the prostate tumor.

Original languageEnglish (US)
Pages (from-to)183-189
Number of pages7
JournalCurrent urology reports.
Volume6
Issue number3
StatePublished - May 2005

Fingerprint

Prostatic Neoplasms
Neoplasms
Therapeutics
Prostate
Clinical Trials
Survival

ASJC Scopus subject areas

  • Urology

Cite this

Canby-Hagino, E. D., Swanson, G. P., Crawford, E. D., Basler, J. W., Hernandez, J., & Thompson, I. M. (2005). Local and systemic therapy for patients with metastatic prostate cancer: should the primary tumor be treated? Current urology reports., 6(3), 183-189.

Local and systemic therapy for patients with metastatic prostate cancer : should the primary tumor be treated? / Canby-Hagino, Edith D.; Swanson, Gregory P; Crawford, E. David; Basler, Joseph W; Hernandez, Javier; Thompson, Ian M.

In: Current urology reports., Vol. 6, No. 3, 05.2005, p. 183-189.

Research output: Contribution to journalArticle

Canby-Hagino, ED, Swanson, GP, Crawford, ED, Basler, JW, Hernandez, J & Thompson, IM 2005, 'Local and systemic therapy for patients with metastatic prostate cancer: should the primary tumor be treated?', Current urology reports., vol. 6, no. 3, pp. 183-189.
Canby-Hagino ED, Swanson GP, Crawford ED, Basler JW, Hernandez J, Thompson IM. Local and systemic therapy for patients with metastatic prostate cancer: should the primary tumor be treated? Current urology reports. 2005 May;6(3):183-189.
Canby-Hagino, Edith D. ; Swanson, Gregory P ; Crawford, E. David ; Basler, Joseph W ; Hernandez, Javier ; Thompson, Ian M. / Local and systemic therapy for patients with metastatic prostate cancer : should the primary tumor be treated?. In: Current urology reports. 2005 ; Vol. 6, No. 3. pp. 183-189.
@article{3cdc82b6f37d428d8c263a1da65a3a99,
title = "Local and systemic therapy for patients with metastatic prostate cancer: should the primary tumor be treated?",
abstract = "Data from well-designed, prospective clinical trials are lacking to support treatment of primary tumor in men diagnosed with metastatic prostate cancer. However, a growing body of evidence suggests that treatment of the primary tumor may enhance cancer control and survival in some men. This evidence is examined and recommendations are made for identifying patients with metastatic prostate cancer who may benefit from definitive treatment of the prostate tumor.",
author = "Canby-Hagino, {Edith D.} and Swanson, {Gregory P} and Crawford, {E. David} and Basler, {Joseph W} and Javier Hernandez and Thompson, {Ian M.}",
year = "2005",
month = "5",
language = "English (US)",
volume = "6",
pages = "183--189",
journal = "Current Urology Reports",
issn = "1527-2737",
publisher = "Current Science, Inc.",
number = "3",

}

TY - JOUR

T1 - Local and systemic therapy for patients with metastatic prostate cancer

T2 - should the primary tumor be treated?

AU - Canby-Hagino, Edith D.

AU - Swanson, Gregory P

AU - Crawford, E. David

AU - Basler, Joseph W

AU - Hernandez, Javier

AU - Thompson, Ian M.

PY - 2005/5

Y1 - 2005/5

N2 - Data from well-designed, prospective clinical trials are lacking to support treatment of primary tumor in men diagnosed with metastatic prostate cancer. However, a growing body of evidence suggests that treatment of the primary tumor may enhance cancer control and survival in some men. This evidence is examined and recommendations are made for identifying patients with metastatic prostate cancer who may benefit from definitive treatment of the prostate tumor.

AB - Data from well-designed, prospective clinical trials are lacking to support treatment of primary tumor in men diagnosed with metastatic prostate cancer. However, a growing body of evidence suggests that treatment of the primary tumor may enhance cancer control and survival in some men. This evidence is examined and recommendations are made for identifying patients with metastatic prostate cancer who may benefit from definitive treatment of the prostate tumor.

UR - http://www.scopus.com/inward/record.url?scp=32844475200&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=32844475200&partnerID=8YFLogxK

M3 - Article

C2 - 15869722

AN - SCOPUS:32844475200

VL - 6

SP - 183

EP - 189

JO - Current Urology Reports

JF - Current Urology Reports

SN - 1527-2737

IS - 3

ER -